# Research Evaluating an Investigational Medication for Erectile Dysfunction - Post-Prostatectomy

> **NCT00895011** · PHASE3 · COMPLETED · sponsor: **VIVUS LLC** · enrollment: 298 (actual)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** Placebo
- **DRUG:** Avanafil
- **DRUG:** Avanafil

## Key facts

- **NCT ID:** NCT00895011
- **Lead sponsor:** VIVUS LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 298 (ACTUAL)
- **Last updated:** 2012-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00895011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00895011, "Research Evaluating an Investigational Medication for Erectile Dysfunction - Post-Prostatectomy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00895011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*